Addressing the risk of bacterial contamination in platelets: a hospital economic perspective-Reference-Cited by-同舟云学术

Addressing the risk of bacterial contamination in platelets: a hospital economic perspective

Published:2017-07-13 Issue:10 Volume:57 Page:2321-2328
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Li Justin W.¹,Brecher Mark E.²³,Jacobson Jessica L.⁴,Harm Sarah K.⁵,Chen Dorothy¹,El‐Gamil Audrey¹,Dobson Al¹,Mintz Paul D.⁶

Affiliation:

1. Dobson DaVanzo & Associates, LLCVienna Virginia

2. Laboratory Corporation of America HoldingsBurlington North Carolina

3. University of North Carolina at Chapel Hill School of MedicineChapel Hill North Carolina

4. New York University School of MedicineNew York New York

5. University of Vermont Medical CenterBurlington Vermont

6. Verax Biomedical, IncorporatedMarlborough Massachusetts.

Funder

Verax Biomedical, Incorporated

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.14216

Reference34 articles.

1. Bacterial risk control strategies for blood collection establishments and transfusion services to enhance the safety and availability of platelets for transfusion. Draft guidance for industry [Internet]. Silver Spring (MD): U.S. Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research;2016Mar [cited 2017 Jan 09]. Available from:http://www.fda.gov/downloads/Guidances/Blood/UCM425952.pdf.

2. Detection of bacterial contamination in prestorage culture-negative apheresis platelets on day of issue with the Pan Genera Detection test

3. Detection of septic transfusion reactions to platelet transfusions by active and passive surveillance

4. Trends in United States blood collection and transfusion: results from the 2013 AABB Blood Collection, Utilization, and Patient Blood Management Survey

5. Revised recommendations for reducing the risk of Zika virus transmission by blood and blood components. Guidance for industry. Silver Spring (MD): U.S. Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research;2016Aug [cited 2016 Oct 4]. Available from:http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Blood/UCM518213.pdf

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro Hemostatic Functions of Cold-Stored Platelets;Transfusion Medicine and Hemotherapy;2023-11-16

2. Inhibition of GPIb-α-mediated apoptosis signaling enables cold storage of platelets;Haematologica;2023-06-22

3. Platelet components and bacterial contamination: hospital perspective 2022;Hematology;2022-12-09

4. Improvement in Platelet Product Wastage and Reduction of Costs through Implementation of the Pan Genera Detection Test;Laboratory Medicine;2022-10-15

5. Clinical and economic impacts of large volume delayed sampling and pathogen reduction technology platelet processing strategies in the United States;Transfusion;2021-07-21